- Home
- TLSA vs ANIX Comparison
TLSA vs ANIX Comparison
Compare TLSA & ANIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TLSA
- ANIX
- Stock Information
- Founded
- TLSA 2013
- ANIX 1982
- Country
- TLSA United Kingdom
- ANIX United States
- Employees
- TLSA N/A
- ANIX N/A
- Industry
- TLSA Biotechnology: Pharmaceutical Preparations
- ANIX Biotechnology: Pharmaceutical Preparations
- Sector
- TLSA Health Care
- ANIX Health Care
- Exchange
- TLSA Nasdaq
- ANIX Nasdaq
- Market Cap
- TLSA 87.8M
- ANIX 82.7M
- IPO Year
- TLSA 2000
- ANIX 1987
- Fundamental
- Price
- TLSA $0.68
- ANIX $3.11
- Analyst Decision
- TLSA
- ANIX Strong Buy
- Analyst Count
- TLSA 0
- ANIX 2
- Target Price
- TLSA N/A
- ANIX $8.50
- AVG Volume (30 Days)
- TLSA 1.2M
- ANIX 136.7K
- Earning Date
- TLSA 02-18-2025
- ANIX 03-11-2025
- Dividend Yield
- TLSA N/A
- ANIX N/A
- EPS Growth
- TLSA N/A
- ANIX N/A
- EPS
- TLSA N/A
- ANIX N/A
- Revenue
- TLSA N/A
- ANIX N/A
- Revenue This Year
- TLSA N/A
- ANIX N/A
- Revenue Next Year
- TLSA N/A
- ANIX N/A
- P/E Ratio
- TLSA N/A
- ANIX N/A
- Revenue Growth
- TLSA N/A
- ANIX N/A
- 52 Week Low
- TLSA $0.41
- ANIX $2.07
- 52 Week High
- TLSA $1.74
- ANIX $4.67
- Technical
- Relative Strength Index (RSI)
- TLSA 38.37
- ANIX 64.69
- Support Level
- TLSA $0.65
- ANIX $2.89
- Resistance Level
- TLSA $0.70
- ANIX $3.05
- Average True Range (ATR)
- TLSA 0.08
- ANIX 0.20
- MACD
- TLSA -0.01
- ANIX 0.06
- Stochastic Oscillator
- TLSA 3.97
- ANIX 94.32
About TLSA Tiziana Life Sciences Ltd.
Tiziana Life Sciences Ltd is a clinical-stage biotechnology company that specializes in the developing transformative therapies for neurodegenerative and lung diseases. Its clinical pipeline includes drug assets for Secondary Progressive Multiple Sclerosis, ALS. Alzheimer's, Crohn's Disease and KRAS+ NSCLC. Tiziana is led by a team of qualified executives with extensive drug development and commercialization experience.
About ANIX Anixa Biosciences Inc.
Anixa Biosciences Inc, a cancer-focused biotechnology company, developing vaccines and therapies that are focused on critical unmet needs in oncology. The company is developing both diagnostics and therapeutics to detect cancer early, which is curable, and to treat those afflicted once diagnosed. Its segment includes CAR-T Therapeutics; Cancer Vaccines; Anti-Viral Therapeutics and others.